Abstract
ADMINISTRATION of lathyrogenic agents to growing animals induces a variety of connective tissue malformations such as exostoses, hernias and aneurysms. Some authors claim that it is possible to suppress these malformations of lathyrism by treatment with corticoids, thyroxine and some antirheumatic drugs1–3. The basic defect of connective tissue in lathyrism is the alteration of the molecular aggregation of collagen, resulting in increased solubility in acid or neutral salt solutions4. In this study an attempt was undertaken to influence the increased solubility of collagen in lathyrism by treatment with hydrocortisone.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
